中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
10期
205-206
,共2页
儿童过敏性紫癜%泼尼松%过敏性血管炎
兒童過敏性紫癜%潑尼鬆%過敏性血管炎
인동과민성자전%발니송%과민성혈관염
Children with al ergic purpura%Prednisone%Al ergic vasculitis
目的：研究儿童过敏性紫癜症使用泼尼松治疗的临床可行性和安全性。方法对78例过敏性紫癜患儿来进行研究分析，全部患儿的临床发病到治疗间隔不超过两周，对照组共38例患者，实验组共40例患者。对照组进行常规治疗，实验组使用常规治疗和泼尼松口服治疗，对两组患者均进行了半年的观察，对比患者的症状改善情况。结果对患者进行三周的治疗后，患者的皮肤紫癜、消化道症状、关节肿痛等的恢复时间要比实验组长，P<0.05，半年后回访中，实验组患儿没有出现副作用和复发病例。结论过敏性紫癜患儿接受糖皮质激素药物泼尼松治疗的疗效突出。
目的：研究兒童過敏性紫癜癥使用潑尼鬆治療的臨床可行性和安全性。方法對78例過敏性紫癜患兒來進行研究分析，全部患兒的臨床髮病到治療間隔不超過兩週，對照組共38例患者，實驗組共40例患者。對照組進行常規治療，實驗組使用常規治療和潑尼鬆口服治療，對兩組患者均進行瞭半年的觀察，對比患者的癥狀改善情況。結果對患者進行三週的治療後，患者的皮膚紫癜、消化道癥狀、關節腫痛等的恢複時間要比實驗組長，P<0.05，半年後迴訪中，實驗組患兒沒有齣現副作用和複髮病例。結論過敏性紫癜患兒接受糖皮質激素藥物潑尼鬆治療的療效突齣。
목적：연구인동과민성자전증사용발니송치료적림상가행성화안전성。방법대78례과민성자전환인래진행연구분석，전부환인적림상발병도치료간격불초과량주，대조조공38례환자，실험조공40례환자。대조조진행상규치료，실험조사용상규치료화발니송구복치료，대량조환자균진행료반년적관찰，대비환자적증상개선정황。결과대환자진행삼주적치료후，환자적피부자전、소화도증상、관절종통등적회복시간요비실험조장，P<0.05，반년후회방중，실험조환인몰유출현부작용화복발병례。결론과민성자전환인접수당피질격소약물발니송치료적료효돌출。
Objective To analyze clinical feasibility and safety of prednisone in treatment of children al ergic purpura. Methods 78 patients with children al ergic purpura were selected into control group(38 cases)and experimental group(40 cases). The intervals from clinical onset to treatment were less than two weeks. The patients in control group received routine treatment,and the experimental group patients received routine treatment and prednisone oral treatment. The patients in two groups were observed for half a year,the improvements of symptoms were compared. Results The recovery time of skin purpura,gastrointestinal symptoms ,joint swel ing and pain were longer than experimental group three weeks after treatment,P<0.05. There was no side effects and recurrence in the experimental group on the visit after six months. Conclusion The curative effect of prednisone(glucocorticoid drug)in treatment of children al ergic purpura is remarkable.
